Latest / Community Health Media
Dr. Ruta Rao & Dr. VK Gadi - Can T-DXd Change Early HER2+ Breast Cancer Forever?
In this expert discussion, Dr. VK Gadi and Dr. Ruta Rao break down the data that’s reshaping treatment for HER2-positive breast cancer — from DESTINY-Breast 05 and 11 to the first-line metastatic implications of DESTINY-Breast 09.
They explore what the numbers really mean for patients with residual disease, how CNS risk and toxicity factor into decision-making, and where T-DXd may (or may not) replace existing standards of care.
A candid, data-driven conversation for clinicians navigating HER2+ treatment today — and preparing for what comes next.
#HER2Positive #BreastCancer #TDXd #Oncology…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.